In every case, the rectal cancer disappeared after immunotherapy — without the need for the standard treatments of radiation or surgery.

Researchers have discovered a rapid and sustainable way to synthetically produce a promising cancer-fighting compound right in the lab.

The MSK clinical trial was investigating — for the first time ever — if immunotherapy alone could beat rectal cancer that had not spread.

One injection of a candidate monoclonal antibody (mAb) known as L9LS was found to be safe and highly protective in adults exposed to malaria

The MSK clinical trial was investigating — for the first time ever — if immunotherapy alone could beat rectal cancer that had not spread.

The virus has been designed specifically to kill cancer and works by enhancing the body's immune response against cancer cells.